Next 20 article - Clinical Trials - Phase 1

Clinical Trials - Phase 1

Your participation in clinical trials can help find a cure for MS.

A clinical trial (also called clinical research or a clinical study) aims to ensure treatments that are administered are safe and effective. Trials can also be used to learn how the body and disease responds to a treatment. This may open a window into the disease and how it works with the aim to develop better treatments.

Clinical trials are undertaken in carefully monitored and regulated phases:

Phase I trials are the first of several hurdles a new treatment must jump before it can reach patients, making it a critical step in the life of promising new treatments. The intention of Phase I is to find out the safe dosage, side effects, how the body copes with the treatment and if the treatment affects MS.

Currently there is a Phase I trial underway at the Austin Hospital Neurology Department and the Centre for Clinical Studies to investigate the use of an experimental drug in MS. The study is suitable for people with relapsing MS, aged between 18 and 55 years and who are not currently on treatment. For more information contact the Centre for Clinical Studies on 1800 243 733 or email contactus@centreforclinicalstudies.com

To review a list of all current clinical trials including opportunities to participate, please visit the MSRA Clinical
Trials Network website: www.mstrials.org.au  

 To view the other articles in Next 20, please click on the link below

• Lessening lesions 
• CCSVI and MS 
• Clinical Trials - Phase 1 (article above)
• Hidden costs of MS
• The 'Black Hole' of MS
• F5m Updates
• Walkers and Supporters join M2S

To download a copy of the Next 20 newsletter please click here